The firm expects a study on the company’s treatment for obesity will yield positive results.
Goldman Sachs says this little-known biotech stock can double on potentially ‘blockbuster’ revenue
Posted in Uncategorized.
The firm expects a study on the company’s treatment for obesity will yield positive results.